TheJakartaPost

Please Update your browser

Your browser is out of date, and may not be compatible with our website. A list of the most popular web browsers can be found below.
Just click on the icons to get to the download page.

Jakarta Post

LINE launches new BT21 stickers to support vaccination initiative

All proceeds from BT21: Protect You by LINE x IVI will be donated to the International Vaccine Institute. 

News Desk (The Jakarta Post)
Jakarta
Wed, July 1, 2020

Share This Article

Change Size

LINE launches new BT21 stickers to support vaccination initiative Stickers from the BT21: Protect You by LINE x IVI collection designed to remind users to stay healthy. (International Vaccine Institute/File)

M

essaging app LINE has launched a new collection of BT21 stickers in collaboration with the International Vaccine Institute (IVI), a non-profit intergovernmental organization in South Korea.

Named BT21: Protect You by LINE x IVI, the collection consists of 24 stickers designed to lift users’ spirits and encourage them to stay healthy. It is available for purchase until Oct. 31 and is priced at 100 LINE Coins (Rp 23,000 or US$ 1.99).

All proceeds will be donated to IVI to support the organization’s child immunization plans and new vaccines development, including for COVID-19.

Read also: Samsung reveals BTS edition of Galaxy S20+, Buds+

Launched in 1997 as an initiative of the United Nations Development Program (UNDP), IVI aims to make vaccines available and accessible for people in need.

BT21 is a collection of characters from a collaboration between popular South Korean boyband BTS and LINE. Eight characters were created by the group’s members.

Launched in 2017, BT21 products included plush toys, cushions, passport cases, mugs, clothes and fashion accessories. BT21 has also collaborated with multiple companies, including Paris Baguette, Converse and Uniqlo. (wir/wng)

Your Opinion Matters

Share your experiences, suggestions, and any issues you've encountered on The Jakarta Post. We're here to listen.

Enter at least 30 characters
0 / 30

Thank You

Thank you for sharing your thoughts. We appreciate your feedback.